Boc-D-Lys(Z)-OH

Catalog No. :
ACDKPF416
CAS No. :
55878-47-2
Molecular Formula :
C19H28N2O6
Molecular Weight :
380.44

IUPAC Name:N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-D-lysine

Boc-D-Lys(Z)-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$55.00Login to see priceIn stockInquiry
100g98%$206.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBoc-D-Lys(Z)-OH
IUPAC NameN6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-D-lysine
MDL No.MFCD00038262
Molecular FormulaC19H28N2O6
Molecular Weight380.44
SMILESO=C(O)[C@H](NC(OC(C)(C)C)=O)CCCCNC(OCC1=CC=CC=C1)=O
InChI KeyBDHUTRNYBGWPBL-OAHLLOKOSA-N
SynonymBOC-N-EPSILON-Z-D-LYSINE;BOC-D-LYSINE(CBZ);BOC-D-LYSINE(Z)-OH;N-ALPHA-BUTOXYCARBONYL-N-EPSILON-CARBOBENZOXY-D-LYSINE;N-ALPHA-BOC-N-EPSILON-BENZYLOXYCARBONYL-D-LYSINE;N-ALPHA-TERT-BUTYLOXYCARBONYL-N-EPSILON-BENZYLOXYCARBONYL-D-LYSINE;N2-[(1,1-Dimethylethoxy)Carbonyl]-N6-[(Phenylmethoxy)Carbonyl]-D-Lysine;Nalpha-Boc-Nepsilon-Z-D-lysine
CAS No.55878-47-2
PubChem CID7269335

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDKPF416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYRTC817 route compound structure diagram
    ACYRTC81734404-32-5 In Stock
  4. Then
  5. ACDKPF416 route product structure diagram
    ACDKPF41655878-47-2 In Stock
Inquiry

2. ACDKPF416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXGPY204 route compound structure diagram
    ACXGPY204106719-44-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKPF416 route product structure diagram
    ACDKPF41655878-47-2 In Stock
Inquiry

Comments (0)